Purple Biotech Provides Corporate Update and Reports First Half 2021 Financial Results

Purple Biotech Ltd. (“Purple Biotech”, or the “Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and …

( read original story …)